What Is Kratom? Plant, Origin and Research Overview

In commercial contexts, “kratom” usually refers to dried leaf material from Mitragyna speciosa sold as a botanical product[5][6]. This article explains what kratom is botanically, where it originates, which plant constituents have been studied and how international research and regulatory discussion currently approach it[1][6][7]. It is factual information and does not recommend consumption or use.

---

Botanical classification: kratom as a tropical tree

Mitragyna speciosa belongs to the order Gentianales and the family Rubiaceae—the same plant family as coffee (Coffea) and cinchona (Cinchona)[2][3]. Within the Rubiaceae, it is assigned to the subfamily Cinchonoideae and the tribe Naucleeae, which includes several other botanically and pharmacologically studied species[2][8].

In its natural habitat, the tree can reach approximately 4 to 16 metres depending on location and environmental conditions, with still larger specimens reported occasionally[1][3]. Typical features include a generally straight trunk with pale grey-green bark, visible lenticels and a broad, densely foliated crown[2][3].

The leaves are oval to broadly ovate, dark green and marked by pronounced, regularly arranged lateral veins[1][2]. Mitragyna speciosa remains evergreen in most tropical areas, but can behave as a facultatively deciduous tree in cooler or seasonally drier regions, shedding part of its foliage[2][3].

Its flowers occur in spherical, yellowish inflorescences composed of numerous small flowers, often arranged in groups of three at a node[2][8]. They develop into capsule-like fruits containing many small, winged seeds that can be dispersed by wind and water[2][3].

---

Natural range and habitat

Kratom originates in the humid lowlands of Southeast Asia and is reported as native to countries including Thailand, Malaysia, Indonesia, Myanmar, Cambodia, the Philippines and Papua New Guinea[1][3][4]. Its natural distribution is concentrated in regions with high year-round humidity, regular rainfall and nutrient-rich alluvial soils[2][3].

Typical sites include floodplain forests, riverbanks, freshwater swamps and periodically inundated wetlands where groundwater saturates the soil for much of the year[2][3][4]. In these habitats, the trees can form dense stands. Their roots can contribute to riverbank stability and soil retention, alongside other wetland vegetation[2][4].

Kratom is now cultivated outside its original range in some regions, including parts of the United States where outdoor or greenhouse conditions permit growth[6][9]. In temperate climates, however, the tree normally remains much smaller and is sensitive to cold and frost[2][9].

---

Traditional and cultural significance

Historical and ethnobotanical sources describe kratom as part of everyday life in some rural Southeast Asian communities since at least the nineteenth century[1][6][10]. Field studies from Thailand, Malaysia and Indonesia report that kratom leaves were familiar particularly among agricultural workers, fishers and plantation workers and became embedded in local practices[1][6].

Beyond work, kratom appears in social and ritual settings in certain areas, including village gatherings, traditional ceremonies and animist practices[6][10]. The precise forms differ by region, community and historical period and remain subjects of ethnographic research[6][10].

Traditional medical systems in several Southeast Asian countries also describe kratom within a much broader body of knowledge concerning regional plants[1][6][11]. Historical use does not by itself establish clinical safety or efficacy. Contemporary health assessments and regulatory decisions rely increasingly on pharmacological and toxicological evidence[7][12].

---

Constituents: alkaloids and other plant compounds

Scientific research has identified numerous secondary plant compounds in kratom leaves, including more than 40 indole and oxindole alkaloids[7][12]. Composition can vary substantially with genotype, geographical origin, harvest timing and post-harvest processing[7][12].

The best-studied alkaloids include mitragynin—often quantitatively dominant in analysed samples—and 7-hydroxymitragynin, a compound and metabolite described as a potent µ-opioid receptor agonist in animal and in-vitro models[7][12][13]. Other reported alkaloids include speciogynine, speciociliatine, paynantheine and numerous minor constituents whose pharmacology continues to be studied[7][12].

Research using human and mouse liver preparations indicates that CYP3A enzymes convert mitragynin to 7-hydroxymitragynin, which can account for a substantial share of observed µ-opioid receptor-mediated effects in experimental systems[13][14]. Mitragynin and some metabolites have also been investigated as functionally selective, or G-protein-biased, agonists. The implications for effects and adverse events remain an active area of research[13][14].

The leaves also contain chlorophyll, flavonoids, polyphenols, carbohydrates and minerals, as is typical of many evergreen tropical trees[2][12]. This plant matrix can affect extraction, stability and the measured availability of alkaloids and is therefore relevant to analytical and pharmacokinetic research[7][12].

---

Legal classification and international discussion

Kratom’s legal status differs considerably around the world and can change[5][15]. Some jurisdictions control the plant, some regulate particular alkaloids or permit it subject to conditions, and others have no specific national classification[5][15]. A general article cannot establish the current law for a particular delivery address.

At international level, kratom has been discussed by the World Health Organization’s Expert Committee on Drug Dependence (ECDD)[15][16]. Following a pre-review in 2021, the committee did not recommend a critical review leading towards international scheduling under the United Nations drug-control conventions. Kratom, mitragynin and 7-hydroxymitragynin remained under surveillance[15][16].

The European Union Drugs Agency (EUDA) and national authorities publish updated profiles summarising botanical information, known constituents, reported patterns of use, risks, market developments and legal issues[1][5][7]. Anyone considering an order must check the current rules that apply in the destination jurisdiction.

---

Current state of research

The number of scientific publications about kratom has grown markedly, particularly in pharmacology, pharmacokinetics, toxicology and possible interactions with other substances[7][12][17]. Reviews report that kratom alkaloids interact with several receptor systems, including opioid, adrenergic, serotonergic and dopaminergic targets[7][12][17].

Clinical and observational research is examining reported patterns of use, participants’ stated motivations and adverse events observed in real-world settings[17][18]. Pharmacokinetic models are also being refined to describe absorption, distribution, metabolism and excretion of mitragynin and related alkaloids in humans[17].

International expert bodies emphasise the need for further high-quality research into long-term outcomes, interactions and risk profiles[15][17]. A balanced assessment therefore requires continued attention to both scientific evidence and changing regulation.

---

---